PARKINSON'S DISEASE VACCINE IS WELL TOLERATED

The pharmaceutical journal Group

首页> 外文期刊>The pharmaceutical journal >PARKINSON'S DISEASE VACCINE IS WELL TOLERATED

【24h】

PARKINSON'S DISEASE VACCINE IS WELL TOLERATED

机译：帕金森氏病疫苗的定位良好

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

An experimental vaccine to treat Parkinson's disease is well tolerated by patients and elicited an immune response, according to a phase I clinical trial. The results of the trial of the PD01A vaccine, developed by Austrian company AFFiRiS AG, showed that two different doses were safe and well tolerated.

机译：根据I期临床试验，治疗帕金森氏病的实验性疫苗被患者很好地耐受并引发了免疫反应。奥地利公司AFFiRiS AG开发的PD01A疫苗的试验结果表明，两种不同的剂量是安全的，并且耐受性良好。

著录项

来源
《The pharmaceutical journal》 |2014年第7825期|共1页
作者
The pharmaceutical journal Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. PARKINSON'S DISEASE VACCINE IS WELL TOLERATED [J] . The pharmaceutical journal Group The pharmaceutical journal . 2014,第7824a7825期

机译：帕金森氏病疫苗的定位良好
2. Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated [J] . U. Shivraj Sohur, David L. Gray, Sridhar Duvvuri, Neurology and therapy. . 2018,第2期

机译：帕金森氏病1期研究表明，多巴胺D1 / D5激动剂PF-06649751安全且耐受良好
3. Deep brain stimulation for Parkinson's disease: Subcutaneous apomorphine as an alternative for patients unable to tolerate surgery under local anesthesia [J] . de Campos Antonio Martins, Braz Luis, Linhares Paulo Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 2017,第期

机译：对帕金森病的深脑刺激：皮下亚孔啡作为患者无法忍受局部麻醉下的手术的替代品
4. DEVELOPMENT OF A VACCINE PRODUCTION PLATFORM FOR POULTRY DISEASES IN AFRICA: NEWCASTLE DISEASE VIRUS NON-REPLICATIVE ADENOVIRUS-VECTORED VACCINE [C] . Omar Farnos, Hela Kallel, Martha Yami, Conference on vaccine technology VI . 2018

机译：非洲禽病疫苗生产平台的开发：新城疫病毒非复制性腺病毒载体疫苗
5. Mitochondrial function in Parkinson's disease and other neurodegenerative diseases [D] . Gu, Mei. 1998

机译：帕金森氏病和其他神经退行性疾病的线粒体功能
6. Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated [O] . U. Shivraj Sohur, David L. Gray, Sridhar Duvvuri, 2018

机译：帕金森病1期研究表明多巴胺D1 / D5激动剂PF-06649751安全且耐受良好
7. Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated [O] . U. Shivraj Sohur, David L. Gray, Sridhar Duvvuri, 2018

机译：第1阶段Parkinson的疾病研究表明，多巴胺D1 / D5激动剂PF-06649751是安全且耐受性的

PARKINSON'S DISEASE VACCINE IS WELL TOLERATED

摘要

著录项

相似文献

相关主题

期刊订阅